Baqsimi Europeiska unionen - lettiska - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glucagon - cukura diabēts - aizkuņģa dziedzera hormoni, hormoni glycogenolytic - baqsimi ir indicēts, lai ārstētu smagas hipoglikēmijas pieaugušajiem, pusaudžiem un bērniem vecumā no 4 gadiem un vairāk, ar cukura diabēts.

Lyumjev (previously Liumjev) Europeiska unionen - lettiska - EMA (European Medicines Agency)

lyumjev (previously liumjev)

eli lilly nederland b.v. - insulin lispro - cukura diabēts - cukura diabēts - attieksme pret cukura diabētu, pieaugušie, pusaud iem un bērniem vecumā no 1 gada un jaunākām versijām. cukura diabēta ārstēšana pieaugušajiem.

Retsevmo Europeiska unionen - lettiska - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiski līdzekļi - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Mounjaro Europeiska unionen - lettiska - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - cukura diabēts, 2. tips - cukura diabēts - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 un 5.

Rayvow Europeiska unionen - lettiska - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - migrēnas traucējumi - pretsāpju līdzekļi - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Omvoh Europeiska unionen - lettiska - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolīts, čūlas - imūnsupresanti - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Jaypirca Europeiska unionen - lettiska - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - limfoma, mantle-cell - proteīnkināzes inhibitori - treatment of mantle cell lymphoma (mcl).